Newleos Therapeutics

BiotechnologyGrantBoston, USnewleos.com

Latest round

Grant

Last raised

Nov 2026

Total raised

$109M

Investors

6

About Newleos Therapeutics

Based in Massachusetts, US, Newleos Therapeutics, Inc. operates as a neuroscience company which specializes in developing drugs in neuropsychiatry. The company was founded by Longwood, Christoph Westphal, Miguel Sobral and Rob Hadfield.1 selective positive allosteric modulator (PAM) designed to treat anxiety disorders with fewer side effects compared to current therapies. Other clinical-stage assets in the pipeline include NTX-1472 for social anxiety, NTX-2001 for substance use disorders, and NTX-1511 for cognitive impairment. These therapies target novel mechanisms in the brain, such as the GABAA, V1a, and TAAR1 receptors, addressing major unmet needs in neuropsychiatry.

Who invested in Newleos Therapeutics

6 investors across 2 rounds

See all investors in Newleos Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Grant

    Nov 3, 2026

    Amount

    $16M

    Investors

    Locked

  2. Series A

    Feb 10, 2025

    Amount

    $93M

    Investors

    Locked

Questions about Newleos Therapeutics

Who invested in Newleos Therapeutics?

Newleos Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Newleos Therapeutics raised?

Newleos Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Newleos Therapeutics last raise money?

Newleos Therapeutics's most recent round on record is a Grant, in Nov 2026.

What does Newleos Therapeutics do?

Based in Massachusetts, US, Newleos Therapeutics, Inc.

Where is Newleos Therapeutics headquartered?

Newleos Therapeutics is headquartered in Boston, US.

Which VCs invest in companies like Newleos Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Newleos Therapeutics's stage. Their profiles are linked below.

Raising like Newleos Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.